Clinical Trial Update: Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2 [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes completion of Phase 1 and Phase 2 for a study assessing regulatory T cells in Type 1 Diabetes patients treated with interleukin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Interleukin-2 (Aldesleukin) (aldesleukin)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED